The nice people at Oncology Central sent their update today… Much of it went over my head (I can’t pretend it didn’t), but I suspect some of it has stuck…
Article of the week
 |
ASCO 2023: a collection of breaking new stories To help you keep up-to-date with key headlines coming out of the ASCO Annual Meeting 2023 (2−6 June, IL, USA), we have put together a collection of the latest news stories.
|
Latest news |
 |
A study has highlighted favorable survival results for advanced cervical cancer patients given pembrolizumab plus chemotherapy, with or without bevacizumab; supporting a possible new standard of care for the first-line treatment for this patient population. |
 |
Two hospitals, one in Mexico and one in the US, joined forces to seek to improve outcomes for pediatric leukemia patients. The study highlighted stark improvements in survival for these children when collaborative initiatives were implemented. |
 |
Findings
from the examination of racial disparities in mortality rates in
gastrointestinal cancer patients, following Medicaid expansion, have
demonstrated encouraging results.
No comments:
Post a Comment